NEI biological homeostasis regulation technology for the treatment of dwarfism how?

Dwarf patients due to their short stature, and therefore in the image and thought often bring great pressure and distress, for this reason, the medical profession has always been in the research of dwarfism to crack the mystery, to maximize the change of their short state. According to the new theory of Nobel biomedical science: "NEI biological homeostasis regulation technology" successfully deciphered the code of dwarfism Based on the new medical theory of biomedical scientists Wishaws, Faulhard, China, Japan, the United States, South Korea, four national children's medical centers jointly researched "BCT biological intervention technology" launched a clinical trial. BCT Biological Intervention Technology" was put on clinical trial. On the basis of BCT biological intervention technology, Shanghai Hongci Children's Hospital's dwarfism expert group has successfully deciphered the code of dwarfism, and explored and researched NEI biological homeostasis regulation technology which is more suitable for modern people to increase their height according to more than 300 kinds of diseases that cause dwarfism. According to the data, in the clinical application of this technology, 97.2% of the children with dwarfism recovered their normal height, and the review after the treatment showed that there were no side effects, and there was no case of early closure of bones. The principle of "NEI biological homeostasis regulation technology": Chinese and Western medicine + modern high-end biomedicine NEI biological homeostasis regulation technology is to activate the sensitivity of GH to the IGF-1 gene receptor, stimulate the regrowth of osteoarticular and epiphyseal cartilage, and at the same time, to promote the synthesis of proteins, and enhance the uptake and utilization of important elements, such as sodium, potassium, calcium, phosphorus, sulfur, etc., and to promote the development and development of the body. At the same time, it promotes protein synthesis, enhances the intake and utilization of important elements such as sodium, potassium, calcium, phosphorus, sulfur, etc., and promotes the metabolism of the human body, so that the body grows naturally. At the same time, this technology combines the essence of Chinese medicine, Western medicine and modern high-end biomedicine, integrating 8 technical features such as precise bone age assessment technology, rapid hormone detection, Chinese medicine successive days of conditioning, gene immune activation, aromatase inhibitors, GABA supplementation, etc. It is the most comprehensive and systematic technology developed by the medical profession so far, and is now being clinically applied all over the world. Advantages of "NEI Bio-stabilization Technology": safe, efficient and painless 1. Safety: NEI Bio-stabilization Technology is non-invasive, safe, simple in clinical operation, and with long-lasting efficacy; it also overcomes the drawbacks of traditional treatments such as high pain and difficulty in acceptance. 2. 2, high efficiency, NEI biological homeostasis regulation technology collection and integration of a variety of effects in one, including meridian science, yin and yang balance theory, the theory of nerve cross and holographic effect, the treatment of dwarfism has played an irreplaceable clinical effect. "NEI Biological Homeostasis Regulation Technology: Nearly 10,000 cases of children with dwarfism realize the dream of rapid height increase BCT biological intervention technology, after the success of clinical application in Japan and South Korea, China's health care sector began to pay attention to it, and through the cooperation of many aspects, "NEI Biological Homeostasis Regulation Technology Through the cooperation of many aspects, "NEI biological homeostasis regulation technology" was successfully developed in Shanghai Hongci Children's Hospital, a national key hospital specializing in children's growth and development, which has helped nearly 10,000 cases of children with dwarfism to realize their dream of rapid height increase since its clinical application. Since its clinical application, the hospital has helped nearly 10,000 cases of children with dwarfism realize their dream of rapid height increase, and the hospital has been awarded the honorary titles of "National Key Specialized Hospital for Children's Growth and Development" and "Authoritative Diagnosis and Treatment Demonstration Base for Dwarfism in China". Shanghai Hongci Children's Hospital attracts and builds a team of medical experts with rich clinical experience, leading the way forward for modern medical treatment is the original intention of Shanghai Hongci Children's Hospital, and is also a strong guarantee for Hongci to achieve the brand of specialized hospitals in Shanghai. Hongci start from themselves, constantly improve medical research, create conditions, attracted a large number of medical experts with the highest standard of medical team. MOGT biological target repair technology, effectively solved the traditional medicine can not effectively treat neurological disorders of this problem, for the realization of the goal of the whole of humanity's health set off a brand new page in history. At the same time, it is announced that various neurological diseases such as ADHD, Tourette's syndrome, autism, enuresis, other syndromes (learning difficulties, cerebral developmental insufficiency, lead poisoning, attention deficit disorder) will be treated more effectively. At present, the technology has successfully applied for the international PCT, China, the United States, Japan, the European Union and other invention patents, for the diagnosis and treatment of neurological disorders has brought an epoch-making leap, and pointed out the direction of clinical research and development. Since its establishment, Shanghai Hongci Children's Hospital has always paid attention to new medical developments at home and abroad, and has taken the lead in introducing a number of high-precision and advanced medical equipments and technologies from the U.S., Sweden, Australia and other countries. With a forward-looking and innovative thinking, the center introduces international advanced medical management mode and employs authoritative pediatric experts to lead the high-level technical team. Hospital experts, with the pediatric neurological diseases of excellent professional and technical level and many years of rich clinical experience, will be the latest international research results directly used in clinical diagnosis and treatment, and constantly solve the bottleneck in the field of ADHD, Tourette's Syndrome, the effect is remarkable.